183 related articles for article (PubMed ID: 2564958)
1. Haemopoietic growth factors 2: clinical applications.
Metcalf D
Lancet; 1989 Apr; 1(8643):885-7. PubMed ID: 2564958
[No Abstract] [Full Text] [Related]
2. [Colony-stimulating factors. Therapeutic applications].
Kusminsky GD; Koziner B
Sangre (Barc); 1990 Oct; 35(5):381-7. PubMed ID: 2291148
[No Abstract] [Full Text] [Related]
3. The role of recombinant hematopoietic growth factors in blood diseases.
Jimenez JJ; Vargas-Cuba R; Temple JD
Adv Intern Med; 1990; 35():393-414. PubMed ID: 2405600
[No Abstract] [Full Text] [Related]
4. Clinical significance of the haemopoietic growth factors.
Devereux S; Linch DC
Br J Cancer; 1989 Jan; 59(1):2-5. PubMed ID: 2667609
[No Abstract] [Full Text] [Related]
5. Effect of treatment with rhGM-CSF and low-dose cytosine arabinoside on leukemic blast cells in patients with myelodysplastic syndromes.
Hoelzer D; Ganser A; Ottmann OG; Höffken K; Becher R; Lutz D; Krieger O; Diehl V; Lathan B; Boogaerts MA
Haematol Blood Transfus; 1990; 33():763-9. PubMed ID: 2182466
[No Abstract] [Full Text] [Related]
6. Hematopoietic colony-stimulating factors.
Andreeff M; Welte K
Semin Oncol; 1989 Jun; 16(3):211-29. PubMed ID: 2471272
[No Abstract] [Full Text] [Related]
7. Clinical use of growth factors in the myelodysplastic syndromes.
Stein RS
Am J Med Sci; 1994 May; 307(5):360-7. PubMed ID: 7513498
[No Abstract] [Full Text] [Related]
8. In vitro and in vivo action of recombinant human GM-CSF (rhGM-CSF) in patients with myelodysplastic syndromes.
Hoelzer D; Ganser A; Völkers B; Greher J; Walther F
Blood Cells; 1988; 14(2-3):551-9. PubMed ID: 3067785
[TBL] [Abstract][Full Text] [Related]
9. Biological molecules in the treatment of hematological disorders.
Kurzrock R; Talpaz M; Gutterman U
Sangre (Barc); 1989 Feb; 34(1):53-8. PubMed ID: 2469130
[No Abstract] [Full Text] [Related]
10. Revisiting the use of recombinant erythropoietin in myelodysplastic syndromes.
Musto P
Clin Lymphoma; 2005 Jun; 6(1):52-5. PubMed ID: 15989709
[No Abstract] [Full Text] [Related]
11. The myelodysplastic syndromes: biology and implications for management.
List AF; Garewal HS; Sandberg AA
J Clin Oncol; 1990 Aug; 8(8):1424-41. PubMed ID: 1696311
[TBL] [Abstract][Full Text] [Related]
12. [Endogenous regulators of hematopoiesis and their role in the therapy of leukemias].
Svirnovskiĭ AI
Ter Arkh; 1988; 60(5):152-6. PubMed ID: 3051485
[No Abstract] [Full Text] [Related]
13. [Current status of the clinical application of hematopoietic growth factors in oncology].
Karthaus M; Ganser A
Ther Umsch; 1996 Nov; 53(11):863-73. PubMed ID: 8984692
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human granulocyte-colony stimulating factor on hematopoietic reconstitution after autologous bone marrow transplantation in primates.
Gillio AP; Bonilla MA; Potter GK; Gabrilove JL; O'Reilly RJ; Souza LM; Welte K
Transplant Proc; 1987 Dec; 19(6 Suppl 7):153-6. PubMed ID: 3321642
[No Abstract] [Full Text] [Related]
15. [Growth and hematopoietic differentiation factors].
Symann M; Chatelain C; Agaliotis D
Pathol Biol (Paris); 1989 Feb; 37(2):101-3. PubMed ID: 2496392
[No Abstract] [Full Text] [Related]
16. Regulation of endogenous erythropoietin levels in anemia associated with myelodysplastic syndromes.
Vadhan-Raj S; Hittelman WN; Lepe-Zuniga JL; Gutterman JU; Broxmeyer HE
Blood; 1990 Apr; 75(8):1749-50. PubMed ID: 2183890
[No Abstract] [Full Text] [Related]
17. The clinical use of hematopoietic growth factors.
Appelbaum FR
Semin Hematol; 1989 Jul; 26(3 Suppl 3):7-14. PubMed ID: 2477905
[TBL] [Abstract][Full Text] [Related]
18. Use of granulocyte-macrophage colony-stimulating factor in patients with malignancy and bone marrow failure.
Shadduck RK; Rosenfeld CS; Sulecki M; Phillips N; Przepiorka D; Earle M; Stoller R; Jacobs S
Int J Cell Cloning; 1990 Jan; 8 Suppl 1():303-12; discussion 312-3. PubMed ID: 2182742
[TBL] [Abstract][Full Text] [Related]
19. [Colony stimulating factor (granulopoietin)].
Niho Y
Nihon Naika Gakkai Zasshi; 1988 Dec; 77(12):1830-6. PubMed ID: 2471760
[No Abstract] [Full Text] [Related]
20. Clinical application of recombinant erythropoietin in myelodysplasia.
Mittelman M; Lessin LS
Hematol Oncol Clin North Am; 1994 Oct; 8(5):993-1009. PubMed ID: 7852220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
